{"id":"NCT01212757","sponsor":"Amgen","briefTitle":"PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09-27","primaryCompletion":"2012-07-26","completion":"2017-01-25","firstPosted":"2010-10-01","resultsPosted":"2014-05-19","lastUpdate":"2020-05-06"},"enrollment":488,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Apremilast 20mg","otherNames":["CC-10004"]},{"type":"DRUG","name":"Apremilast 30mg","otherNames":["CC-10004"]},{"type":"DRUG","name":"Placebo + 20 mg Apremilast","otherNames":["Placebo","CC-10004"]},{"type":"DRUG","name":"Placebo + 30 mg Apremilast","otherNames":["Placebo","CC-10004"]}],"arms":[{"label":"Apremilast 20mg","type":"EXPERIMENTAL"},{"label":"Apremilast 30mg","type":"EXPERIMENTAL"},{"label":"Placebo + 20 mg Apremilast","type":"PLACEBO_COMPARATOR"},{"label":"Placebo + 30 mg Apremilast","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis.\n\nApremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.","primaryOutcome":{"measure":"Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 16","timeFrame":"Baseline and Week 16","effectByArm":[{"arm":"Placebo","deltaMin":18.9,"sd":null},{"arm":"Apremilast 20 mg","deltaMin":37.4,"sd":null},{"arm":"Apremilast 30 mg","deltaMin":32.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0060"},{"comp":"OG000 vs OG001","p":"0.0002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":4},"locations":{"siteCount":98,"countries":["United States","Belgium","Bulgaria","Canada","Czechia","Estonia","France","Germany","Hungary","Italy","Poland","Russia","South Africa","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["27422893","37316690","34536218","31909868","31077258","30018799"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":159},"commonTop":["Diarrhoea","Upper respiratory tract infection","Nausea","Nasopharyngitis","Headache"]}}